menu
    • menu

    Company profile for Transposon Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Transposon is actively engaged in the development of nucleoside inhibitors targeting LINE-1 reverse transcriptase (NRTI) and other agents associated with LINE-1 pathology, including Protein Kinase R inhibitors (PKR). This focus is directed towards addressing neurodegenerative diseases. Notably, TPN-101, identified as their most potent inhibitor of LINE-1 reverse transcriptase, is currently undergoing investigation in two Phase...
    Transposon is actively engaged in the development of nucleoside inhibitors targeting LINE-1 reverse transcriptase (NRTI) and other agents associated with LINE-1 pathology, including Protein Kinase R inhibitors (PKR). This focus is directed towards addressing neurodegenerative diseases. Notably, TPN-101, identified as their most potent inhibitor of LINE-1 reverse transcriptase, is currently undergoing investigation in two Phase 2a clinical trials. This underscores Transposon's commitment to advancing potential treatments for neurodegenerative diseases through the development of innovative therapeutic agents.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Transposon TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Diego, CA 92122
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.transposonrx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Transposon Gets Funding For Alzheimer’s Candidate TPN-101
    Transposon Gets Funding For Alzheimer’s Candidate TPN-101

    09 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transposon-receives-investment-from-the-alzheimers-drug-discovery-foundation-to-support-advancement-of-tpn-101-for-the-treatment-of-alzheimers-disease-302500597.html

    PR NEWSWIRE
    09 Jul 2025
    Share Share
    TPN-101 Joins Healey Trial After C9orf72 ALS Success
    TPN-101 Joins Healey Trial After C9orf72 ALS Success

    28 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transposon-announces-tpn-101-selected-for-inclusion-in-the-phase-23-healey-als-platform-trial-building-on-the-success-of-phase-2-study-in-c9orf72-related-als-302466319.html

    PR NEWSWIRE
    28 May 2025
    Share Share
    Transposon Acquires Portfolio of Novel Nucleoside Analogs
    Transposon Acquires Portfolio of Novel Nucleoside Analogs

    21 Nov 2024

    // CONTRACTPHARMA

    https://www.contractpharma.com//contents/view_breaking-news/2024-11-21/transposon-therapeutics-acquires-portfolio-of-novel-nucleoside-analogs/?widget=listSection

    CONTRACTPHARMA
    21 Nov 2024
    Share Share
    Transposon Expands Pipeline with Acquisition of Nucleoside Analogs
    Transposon Expands Pipeline with Acquisition of Nucleoside Analogs

    21 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transposon-therapeutics-strengthens-and-expands-development-pipeline-with-the-acquisition-of-a-portfolio-of-novel-nucleoside-analogs-for-oncology-302312312.html

    PR NEWSWIRE
    21 Nov 2024
    Share Share
    Transposon to Present TPN-101 Data for C9orf72 ALS/FTD at ALS ONE
    Transposon to Present TPN-101 Data for C9orf72 ALS/FTD at ALS ONE

    06 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transposon-to-present-results-from-phase-2-study-of-tpn-101-for-the-treatment-of-c9orf72-related-alsftd-at-the-7th-annual-als-one-research-symposium-302296819.html

    PR NEWSWIRE
    06 Nov 2024
    Share Share
    Transposon Gets FDA Fast Track For TPN-101 In PSP
    Transposon Gets FDA Fast Track For TPN-101 In PSP

    21 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transposon-receives-us-fda-fast-track-designation-for-tpn-101-for-progressive-supranuclear-palsy-302150783.html

    PR NEWSWIRE
    21 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search